| After Hours: | Change:
After Market Change
|
Volume: | Time: |
| Last | Change (%) | Trade Time | Bid (size) | Ask (size) | Day Volume |
|---|---|---|---|---|---|
Change
|
|||||
| Latest Tick | Prev Close | Open | Low | High | Avg Day Vol (30d) |
| Market Cap | P/E Ratio | EPS (TTM) | 52 Wk Low | 52 Wk High | # of Trades |
| Yield | Dividend | Ex Div Date | Exchange | Last Size | Avg Trade Size |
| Avg Trade Size |
News
LATEST TWEETS - CURATED BY HASH FINANCE
interestingly $CYCC clinical trial "A Pharmacologic Study of CYC065, a #CDK Cyclin Dependent Kinase Inhibitor, in P… https://t.co/t0CiDVH54x
#BREAKING #CANCERCURE #CURECANCER
OPINION BUY WHILE AT .47 CENTS
Cyclacel #Pharmaceuticals Inc #NASDAQ: CYCC*
CYC… https://t.co/bFCu0PWrn8
#BREAKING #CANCERCURE #CURECANCER
OPINION BUY WHILE AT .47 CENTS
Cyclacel #Pharmaceuticals Inc #NASDAQ: CYCC*
CYC… https://t.co/PBvKBctaHA
Cyclacel Pharmaceuticals $CYCC Downgraded to “Sell” at Zacks Investment Research https://t.co/How8mdLy9F
Cyclacel Pharmaceuticals $CYCC Downgraded to “Sell” at Zacks Investment Research https://t.co/VkccJn92iP
Cyclacel Pharmaceuticals $CYCC Downgraded to “Sell” at Zacks Investment Research https://t.co/qu45N0mu88
